IM Cannabis (IMCC) Non-Current Debt (2021 - 2025)
IM Cannabis (IMCC) recorded quarterly Non-Current Debt of $671192.8 in Q4 2025, up 101.21% quarter-over-quarter from $333585.7 in Q4 2024, and up 101.21% on a YoY basis from $333585.7 in Q4 2024.
IM Cannabis (IMCC) Non-Current Debt (2021 - 2025) Analysis & Trends
IM Cannabis' Non-Current Debt history runs 5 years deep, the most recent figure standing at $671192.8 for Q4 2025.
- In Q4 2025, Non-Current Debt rose 101.21% year-over-year to $671192.8; the TTM figure through Dec 2025 stood at $671192.8 (up 101.21% YoY), while the FY2025 annual figure was $671192.8, up 97.2% from the prior year.
- Non-Current Debt was $671192.8 for Q4 2025 at IM Cannabis, up from $333585.7 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $671192.8 in Q4 2025 to a low of $277656.6 in Q2 2022.
- Historically, Non-Current Debt has averaged $321419.4 across 5 years, with a median of $293565.9 in 2022.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt declined 5.48% in 2022, then soared 101.21% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $310987.7 in 2021, then retreated by 5.48% to $293944.5 in 2022, then declined by 1.54% to $289407.0 in 2023, then gained by 15.27% to $333585.7 in 2024, then surged by 101.21% to $671192.8 in 2025.
- The last three Non-Current Debt figures came in at $671192.8 (Q4 2025), $333585.7 (Q4 2024), and $296886.6 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 671,192.76 |
| Dec 31, 2025 | 671,192.76 |
| Dec 31, 2024 | 333,585.70 |
| Dec 31, 2024 | 333,585.70 |
| Sep 30, 2024 | 296,886.63 |
| Sep 30, 2024 | 296,886.63 |
| Jun 30, 2024 | 293,187.36 |
| Jun 30, 2024 | 293,187.36 |
| Mar 31, 2024 | 297,587.40 |
| Mar 31, 2024 | 297,587.40 |
| Dec 31, 2023 | 289,407.00 |
| Dec 31, 2023 | 289,407.00 |
| Sep 30, 2023 | 280,469.86 |
| Sep 30, 2023 | 280,469.86 |
| Jun 30, 2023 | 282,147.48 |
| Jun 30, 2023 | 282,147.48 |
| Mar 31, 2023 | 290,700.67 |
| Mar 31, 2023 | 290,700.67 |
| Dec 31, 2022 | 293,944.47 |
| Dec 31, 2022 | 293,944.47 |